Background With the implementation of primary high-risk human papillomavirus (hrHPV)
screening in the Netherlands, an increase was observed in the number of unnecessary …

Objective We aim to compare the cost‐effectiveness of the old cytology programme with the
new high‐risk human papillomavirus (hrHPV) screening programme, using performance …

Introduction Since 2012, cervical cancer screening has been conducted with a primary high‐
risk human papillomavirus (hrHPV) test and conventional cytology triage in the city of …

Objective Cervical cancer screening by human papillomavirus (HPV) testing requires the
use of additional triage and follow-up analyses. We evaluated women's compliance with and …

The role of high-risk human papillomavirus (hrHPV) testing in primary cervical screening has
not been established. We generated a randomised evaluation design ultimately to clarify …

Background: Forthcoming cervical cancer screening strategies involving human
papillomavirus (HPV) testing for women not vaccinated against HPV infections may increase …

Abstract Background In January 2017, the Dutch cervical cancer screening programme
transitioned from cytomorphological to primary high-risk HPV (hrHPV) DNA screening …

Abstract Background An Organised Cervical Cancer Screening Programme (OCCSP) was
started in Poland in 2006/2007. Each woman aged 25 to 59 is eligible for a free Pap test …

Background: High-risk human papillomavirus (hrHPV)-based cervical cancer screening in
the Netherlands led to a substantial increase in number of colposcopy referrals and low …

Background. High-risk human papilloma virus (hrHPV) testing was added to the cytology
triage of women with equivocal screening smears in the Norwegian programme for cervical …